Answers are grounded in this paper and cite their sources.
A subtype B, E, and D immunoglobulin G capture immunoassay shows promise as a tool for estimating human immunodeficiency virus type 1 seroincidence from cross-sectional surveys, but the test-specific limitations suggest that an adjustment is necessary, and further validation of the assay with populations with divergent subtypes is needed.
No takes yet. Share an insight, caveat, or question.
Xiao et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: